Vimarsana
Biggest News Aggregation in the World

Page 27 - Rxsight Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Rxsight Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Rxsight Inc Today - Breaking & Trending Today

RxSight (NASDAQ:RXST) Earns Buy Rating from Analysts at Needham & Company LLC - Vimarsana News

RxSight (NASDAQ:RXST) Earns Buy Rating from Analysts at Needham & Company LLC

Needham & Company LLC assumed coverage on shares of RxSight (NASDAQ:RXST – Get Rating) in a research note published on Friday morning, Marketbeat Ratings reports. The brokerage issued a buy rating and a $18.00 price target on the stock. Separately, Zacks Investment Research lowered RxSight from a hold rating to a sell rating in a […]

RxSight (NASDAQ:RXST) Stock Rating Upgraded by Zacks Investment Research - Vimarsana News

RxSight (NASDAQ:RXST) Stock Rating Upgraded by Zacks Investment Research

RxSight (NASDAQ:RXST – Get Rating) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a research note issued to investors on Tuesday, Zacks.com reports. According to Zacks, “RxSight Inc. is a commercial-stage medical technology company focuses on patients following cataract surgery. The RxSight Light Adjustable Lens system, comprised of […]

RxSight (NASDAQ:RXST) Stock Rating Lowered by Zacks Investment Research - Vimarsana News

RxSight (NASDAQ:RXST) Stock Rating Lowered by Zacks Investment Research

Zacks Investment Research lowered shares of RxSight (NASDAQ:RXST – Get Rating) from a hold rating to a sell rating in a research note published on Tuesday, Zacks.com reports. According to Zacks, “RxSight Inc. is a commercial-stage medical technology company focuses on patients following cataract surgery. The RxSight Light Adjustable Lens system, comprised of the RxSight […]

RxSight Inc (NASDAQ:RXST) Receives $20.20 Consensus Target Price from Brokerages - Vimarsana News

RxSight Inc (NASDAQ:RXST) Receives $20.20 Consensus Target Price from Brokerages

RxSight Inc (NASDAQ:RXST – Get Rating) has received a consensus rating of “Buy” from the six analysts that are presently covering the stock, Marketbeat Ratings reports. One analyst has rated the stock with a sell rating and five have assigned a buy rating to the company. The average 1 year price objective among analysts that […]

Research Analysts Offer Predictions for RxSight Inc's Q1 2023 Earnings (NASDAQ:RXST) - Vimarsana News

Research Analysts Offer Predictions for RxSight Inc's Q1 2023 Earnings (NASDAQ:RXST)

RxSight Inc (NASDAQ:RXST – Get Rating) – Investment analysts at SVB Leerink issued their Q1 2023 earnings estimates for RxSight in a report issued on Tuesday, March 8th. SVB Leerink analyst D. Antalffy expects that the company will post earnings of ($0.46) per share for the quarter. SVB Leerink currently has a “Buy” rating and […]